Results 101 to 110 of about 3,929 (111)

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. [PDF]

RMD Open
Coates LC, Blanco R, Behrens F, Ogdie A, Van den Bosch F, Ranza R, Klionsky Y, Soliman AM, Chen M, Coombs D, Shi L, Urbanik JR, Iyile T, Lippe R, Gossec L.   +14 more
europepmc   +1 more source

Association of Low Free T3 with Disease Presence and Activity in Ankylosing Spondylitis. [PDF]

Int J Mol Sci
Ciftel E, Klisic A, Kizilkaya B, Cure O, Cure O, Mercantepe F, Karakas SM, Ninić A.   +7 more
europepmc   +1 more source

Assessment of Cardiovascular Risk and Examination of Blood Klotho Levels in Patients with Ankylosing Spondylitis. [PDF]

J Clin Med
Dogan B, Tocoglu A, Tuzun S, Akcay U, Altas A, Gonullu E, Tamer A.   +6 more
europepmc   +1 more source

Efficacy of Tofacitinib in Refractory Axial Spondylarthritis: A Dose-Escalation Study. [PDF]

Cureus
Tazbir AM, Azad MAK, Ahmedullah AK, Hassan MM, Nishu F, Rahman MA, Ealahi TE, Islam MN.   +7 more
europepmc   +1 more source

Erosive costovertebral joint arthritis as a novel feature of ankylosing spondylitis. [PDF]

Quant Imaging Med Surg
Zhang S, Dai X, Xu S, Wang Q, Wang S.
europepmc   +1 more source

Comparative efficacy and safety of imrecoxib versus celecoxib: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zeng X, Dai L, Li Z, Dong X, Liao Z, Chen L, Tan Y, Chen W.   +7 more
europepmc   +1 more source

Body composition, bone mineral density, and functional impairment in axial spondyloarthritis: a 36-month longitudinal study. [PDF]

BMC Musculoskelet Disord
Ceolin C, Bindoli S, Cozzi G, di Marzio B, Lorenzin M, De Rui M, Sfriso P, Doria A, Sergi G, Ramonda R.   +9 more
europepmc   +1 more source

Evaluation of spondyloarthritis-specific health utility based on ASAS health index (U-ASAS-HI) among the disease subtypes: an ancillary analysis from the ASAS-PerSpA study. [PDF]

RMD Open
Calixto OJ, Baraliakos X, Bautista-Molano W, Boonen A, van Kuijk S, Essers I, López-Medina C, Dougados M, Kiltz U.   +8 more
europepmc   +1 more source

Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials. [PDF]

Rheumatol Ther
Reveille JD, Rudwaleit M, Rahman P, Maldonado-Cocco JA, Magrey M, Bolce R, Ng KJ, Gibble TH, Lisse J, Park SY, Kronbergs A, Navarro-Compán V.   +11 more
europepmc   +1 more source